Recent Finacing
Recent Raise
ReNetX Bio develops therapeutics that block axon-growth inhibitors to promote neuronal regeneration in central nervous system injuries, advancing programs for spinal cord injury, stroke and glaucoma into clinical trials.
Focus Areas
Recent Investors
Funding rounds
Investors
See the team members at ReNetX Bio.
